Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 topical spray for hypertension
NCT02998840Phase 2Completed
- Sponsor
- AOBiome
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of B244 in hypertension (HTN), prehypertension, sponsored by AOBiome. Started Nov 2016; status: completed.
02
Drugs
B244
03
Conditions
hypertension (HTN)prehypertension
Beyond the preview
Go deeper on NCT02998840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998840.